Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $989.22, giving the company a market capitalization of 930.68B. It carries a P/E multiple of 36.17 and pays a dividend yield of 62.0%.
On 2026-05-18, Eli Lilly(LLY) stock traded between a low of $978.87 and a high of $1,003.00. Shares are currently priced at $989.22, which is +1.1% above the low and -1.4% below the high.
The Eli Lilly(LLY)'s current trading volume is 2.02M, compared to an average daily volume of 3.22M.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.
LLY News
Key Points Even with growing competition in its core area, Eli Lilly could remain the leader. The company is pursuing other opportunities that may boost its p...
...
Three Biotechs That Are Top Takeover Targets By Alex Sirois Published May 18, 1:55PM EDT Quick Read Viking Therapeutics (VKTX) has a dual GLP-1/GIP agonist in...
Analyst ratings
85%
of 33 ratingsMore LLY News
• Eli Lilly stock is trending lower. Why is LLY stock trading lower? The Bloomberg report on Monday noted that the justices issued the decision without comment,...
Eli Lilly’s (LLY) stock is down 2% on news the U.S. Supreme Court has declined to hear a challenge by the company to a Civil War-era whistleblower law. Claim 55...
A writ of certiorari was denied by the U.S. Supreme Court in the case of Eli Lilly (LLY) v. Streck, Ronald J., meaning that the Court has declined to hear the a...
Eli Lilly (LLY) has become the face of the global obesity drug boom, powered by its GLP-1 (glucagon-like peptide-1) based tirzepatide franchises Mounjaro and Ze...
Earlier this week, Eli Lilly reported detailed late-phase obesity trial results showing long-term weight maintenance with injectable Zepbound and oral Foundayo,...
Wondering whether Eli Lilly's current share price still makes sense after a strong run, or if you might be paying too much for future expectations? This article...
Advertisement Stock performance snapshot and business scale Eli Lilly (LLY) has drawn fresh attention after its recent trading, with the stock closing at US$1...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.